- About
- Research
- Our research units
- Colorectal research at Subiaco
Colorectal research
Our research aims to improve survival and quality of life for patients with colorectal cancer. We integrate benchtop and clinical research activities, providing a unique opportunity for clinicians, scientists and laboratory staff to work closely together to maximise patient care.
Colorectal (bowel) cancer is the second most common cancer in Australia in both men and women, with more than 16,000 people diagnosed each year.
Improvements in diagnosis and treatment have meant that many more people now survive colorectal cancer than was the case 10-20 years ago. However, with more than 5,500 people across the country expected to die from the disease in 2020, there is still much work to be done.
Improvements in diagnosis and treatment have meant that many more people now survive colorectal cancer than was the case 10-20 years ago. However, with more than 5,500 people across the country expected to die from the disease in 2020, there is still much work to be done.
- Improving survival and quality of life after colorectal surgery
- Biomarkers of prognosis and treatment response
- Harnessing the immune system to fight colorectal cancer
- Finding ways to better predict the risk of disease recurrence and metastases
Consultant
Professor Cameron Platell
Postdoctoral Research Fellow
Dr Melanie McCoy
Clinical Research Nurse
Cheryl Penter
Research Officers
Ms Tracey Lee-Pullen
Ms Stephanie Austin
Graduate Research Assistants
Dr Timothy Miller
PhD Student
Ryan Cohen
Associate Investigators
St John of God Subiaco Hospital -
Mr Michael Levitt
Mr Patrick Tan
Dr Jennifer Ryan
Dr Paul Salama
Dr Daphne Tsoi
Dr Thomas van Hagen
Dr Ru-Wen The
Dr Tim Clay
St John of God Murdoch Hospital -
Mr Gregory Makin
Mr Nigel Barwood
Dr Sanjay Mukhedka
Dr Kynan Feeney
Professor Cameron Platell
Postdoctoral Research Fellow
Dr Melanie McCoy
Clinical Research Nurse
Cheryl Penter
Research Officers
Ms Tracey Lee-Pullen
Ms Stephanie Austin
Graduate Research Assistants
Dr Timothy Miller
PhD Student
Ryan Cohen
Associate Investigators
St John of God Subiaco Hospital -
Mr Michael Levitt
Mr Patrick Tan
Dr Jennifer Ryan
Dr Paul Salama
Dr Daphne Tsoi
Dr Thomas van Hagen
Dr Ru-Wen The
Dr Tim Clay
St John of God Murdoch Hospital -
Mr Gregory Makin
Mr Nigel Barwood
Dr Sanjay Mukhedka
Dr Kynan Feeney
Miller, T.J., McCoy, M.J., Lee-Pullen, T.F., Anyaegbu, C.C., Hemmings, C., Bulsara, M.K., Platell, C.F. (2020). The prognostic and Predictive Value of SOX2+ Cell Densities in Patients Treated for Colorectal Cancer. Cancers (Basel), 12 (5):1110. doi: 10.3390/cancers12051110
Maxwell-Smith, C., Hince, D., Cohen, P., Bulsara, M., Boyle, T., Platell, C., Tan, P., Levitt, M., Salama, P., Tan, J., Salfinder, S., Makin, G., Mohan, G., Jimenex-Castuera, R., Hardcastle, S. (2019). A randomised controlled trial of WATAAP to promote phusical activity in colorectal and endometrial cancer survivors. Phychooncology, 28 (7):1420-1429. doi: 10.1002/pon.5090
Anyaegbu, C.C., Lee-Pullen, T.F., Miller, T.J., Abel, T.N., Platell, C.F., McCoy, M.J. (2019). Optimisation of multiplex immunofluorescence for a non-spectral fluorescence scanning system. J Immunol Methods, 472:25-34. doi: 10.1016/j. jim.2019.06.011
Maxwell-Smith, C., Hince, D., Cohen, P., Bulsara, M., Boyle, T., Platell, C., Tan, P., Levitt, M., Salama, P., Tan, J., Salfinder, S., Makin, G., Mohan, G., Jimenex-Castuera, R., Hardcastle, S. (2019). A randomised controlled trial of WATAAP to promote phusical activity in colorectal and endometrial cancer survivors. Phychooncology, 28 (7):1420-1429. doi: 10.1002/pon.5090
Anyaegbu, C.C., Lee-Pullen, T.F., Miller, T.J., Abel, T.N., Platell, C.F., McCoy, M.J. (2019). Optimisation of multiplex immunofluorescence for a non-spectral fluorescence scanning system. J Immunol Methods, 472:25-34. doi: 10.1016/j. jim.2019.06.011
You may be interested in